Ulises D Orlando

Title: Ulises D Orlando: Innovator in Cancer Treatment

Introduction

Ulises D Orlando is a notable inventor based in Pcia. de Buenos Aires, Argentina. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds.

Latest Patents

Orlando holds a patent for an Acyl-CoA synthetase 4 (ACSL4) inhibitory compound. This new compound, identified by formula A, is designed for the treatment of aggressive and/or resistant tumors that express acyl-CoA synthetase 4 (ACSL4) and/or depend on steroid action. The compound has shown promise in inhibiting tumor growth in ACSL4-expressing breast and prostate cancers. Additionally, it inhibits steroid synthesis and sensitizes cells to chemotherapeutic and hormone therapy agents. The patent also covers pharmaceutical compositions that include the ACSL4-inhibitory compound and its combinations with other anticancer agents for therapeutic use.

Career Highlights

Orlando has worked with esteemed institutions such as the National Scientific and Technical Research Council (CONICET) and the National University of Quilmes. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Orlando has collaborated with notable colleagues, including Ernesto J Podestá and Paula M Maloberti. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Ulises D Orlando is a pioneering inventor whose work in developing ACSL4-inhibitory compounds represents a significant advancement in cancer treatment. His contributions continue to influence the field and offer hope for patients facing aggressive tumors.